Pharmaceutical Executive-01-01-2008

Pharmaceutical Executive
Washington Report

January 01, 2008

Pricing, safety, comparative effectiveness, patents, and biosimilars top 2008's policy agenda

Pharmaceutical Executive

We asked seven industry experts to talk about today's best (and worst) pharma icons

Pharmaceutical Executive
Global Report

January 01, 2008

Pharma defends itself against claims made in charity's report on drug access for the world's poor

Pharmaceutical Executive
Tech

January 01, 2008

More control over warehouse data (from drug company to pharmacist) is key to inventory control

Pharmaceutical Executive
Features

January 01, 2008

Pharm Exec asks experts to predict what 2008 has up its sleeve for the industry--from the top line to the bottom line, from R&D to M&As, from Congress to the courts.

Pharmaceutical Executive
From the Editor

January 01, 2008

A new report says FDA is desperately behind on science. At last, a critique we can actually do something about. But will we?

Pharmaceutical Executive
Leadership

January 01, 2008

The departure of Wyeth's legendary CEO prompts a reflection on true leadership-and cooking

Pharmaceutical Executive
Features

January 01, 2008

Welcome to the new employer's market for reps. The Hay Group's annual survey reports how, as the primary sales force contracts, so too does its pay.

Pharmaceutical Executive
Toolkit

January 01, 2008

When it comes to clinical teams, the question of whether or not to outsource brings some untraditional answers

Pharmaceutical Executive

Pharma companies would do well to proceed with extreme caution when entering the blogosphere

Features
Pharmaceutical Executive

January 01, 2008

Novartis' Paul Herrling talks about how Big Pharma can learn from nonprofit R&D and collaborate to get an edge on the drug safety problem.